Has Enrique Rodriguez Olaverri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,427 in general payments to Enrique Rodriguez Olaverri, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Enrique Rodriguez Olaverri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Enrique Rodriguez Olaverri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Enrique Rodriguez Olaverri, MD

Neurology · San Juan, PRNPI 1104929751

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,292 of the $8,427 with a category attached, or 62.8%. 21 manufacturers reported payments, led by Alphatec Spine, Inc at 37.2% of the total. Reporting peaked in 2024 at $3,878 and has fallen 86.9% since, to $507 in 2025.

$8,427in general payments, 2019–2025

Across 76 payments — averaging $110.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alphatec Spine, Inc$3K
Biogen$1K
E.r. Squibb & Sons, L.L.C.$653
Johnson & Johnson$501
Novartis$439
Genentech USA, Inc.$359
plus $2K from 15 others

What the payments were for

Travel & lodging$3,13537%
Food & beverage$5,29263%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alphatec Spine, Inc	1	$3,135
Biogen	23	$1,496
E.r. Squibb & Sons, L.L.C.	13	$653
Johnson & Johnson	6	$501
Novartis	7	$439
Genentech USA, Inc.	3	$359
Sanofi	3	$305
TG Therapeutics, Inc.	2	$275
AbbVie	2	$211
Amneal Pharmaceuticals LLC	3	$155
Medtronic	1	$128
Mallinckrodt Hospital Products Inc.	1	$128
AstraZeneca	1	$125
Amgen	1	$125
Lilly USA, LLC	2	$90
Merck	1	$88
Globus Medical	2	$69
Abbott	1	$59
Sanara Medtech Inc.	1	$53
PBG Puerto Rico LLC	1	$22
Pfizer Pharmaceuticals LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,427 in reported general payments places this provider in the 85th percentile of 129 neurology providers in Puerto Rico.

See all neurology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$8,336

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Avonex Pen (4 Pack)Interferon Beta-1a	14	$112,480
Memantine Hcl ErMemantine Hcl	218	$18,891
Memantine Hcl	532	$11,705
Rivastigmine	68	$8,524
Donepezil Hcl	563	$6,940
Keppra XrLevetiracetam	12	$6,526
Carbidopa-Levodopa ErCarbidopa/Levodopa	42	$3,002
Gabapentin	231	$2,854
DilantinPhenytoin Sodium Extended	11	$1,581
Pregabalin	48	$1,407
Aspirin-Dipyridamole ErAspirin/Dipyridamole	15	$1,205
Carbidopa-LevodopaCarbidopa/Levodopa	23	$903
Levetiracetam	29	$666
Duloxetine Hcl	31	$558
Propranolol Hcl	32	$404

Paid to pharmacies, not to this prescriber.

Other neurology in San Juan

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →